Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CLLS compared with NRXP: revenue, margins and what each company keeps, and the suppliers and customers both name
CLLS
Cellectis S.A.
Change
Mkt cap
Revenue
Revenue
NRXP
NRX Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CLLS
Cellectis S.A.
vs
NRXP
NRX Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
CLLS
No earnings history for CLLS.
NRXP
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±34.2%
▲
+4.89%
×0.14
= implied
CLLS realized, solid
NRXP realized, hatched
One scale, both sides: full bar = 35%
× = |realized| ÷ implied
Source: market data
CLLS
Cellectis S.A.
Change
1.07
▲
+3.88%
· post 1.07
Mkt cap
$107.4M
Revenue
—
NRXP
NRX Pharmaceuticals, Inc.
Change
2.36
▲
+3.98%
· post 2.37
Closed
Nov 6 '26
Mkt cap
$103.0M
Revenue
$6,000
Q2 FY26
vs
Compare
Closed
Nov 6 '26
CLLS
Cellectis S.A.
vs
NRXP
NRX Pharmaceuticals, Inc.
1.07
▲
+3.88%
post 1.07
Price
2.36
▲
+3.98%
post 2.37
$107.4M
Mkt cap
$103.0M
—
Revenue
$6,000
Q2 FY26
Change
Change
CLLS
1.07
▲
+3.88%
vs
NRXP
2.36
▲
+3.98%
Closed
Nov 6 '26